Recent News

• 02.10.2026 - Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
• 01.07.2026 - Genprex Provides Clinical Update on Diabetes Gene Therapy Program
• 01.06.2026 - Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
• 11.24.2025 - Data from Genprex’s Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer

Recent Filings

• 01.09.2026 - 8-K Current report
• 01.09.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 01.07.2026 - 8-K Current report
• 01.07.2026 - EX-99.1 EX-99.1
• 01.06.2026 - 8-K Current report
• 12.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.23.2025 - 4 Statement of changes in beneficial ownership of securities